| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $606.9M | -7.3% |
| Cost of Revenue | $450.7M | -7.0% |
| Gross Profit | $156.2M | -8.3% |
| R&D Expense | $13.2M | -3.6% |
| SG&A Expense | $119.3M | -5.9% |
| Operating Income | $36.6M | -15.3% |
| Pre-tax Income | $35.6M | +6.8% |
| Income Tax | $9.2M | +251.0% |
| Net Income | $26.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.3M | +3.7% |
| Inventory | $133.8M | +7.1% |
| Current Assets | $304.7M | +0.3% |
| Total Assets | $397.6M | -4.2% |
| Current Liabilities | $123.2M | -20.0% |
| Long-term Debt | $50.0M | +0.0% |
| Total Liabilities | $214.8M | -13.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13.8M | -78.9% |
| Capital Expenditures | $2.8M | -13.0% |
| Investing Cash Flow | $1.9M | +113.9% |
| Financing Cash Flow | -$15.4M | +26.4% |
| Free Cash Flow | $11.0M | -82.3% |
| -14.0% |
| EPS (Basic) | $1.95 | -11.4% |
| EPS (Diluted) | $1.95 | -11.4% |
| Stockholders' Equity |
| $182.8M |
| +10.2% |